• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美沙酮维持治疗中的监督性日摄食量、依情况发放可携出院奖励品和非依情况发放可携出院奖励品。

Supervised daily consumption, contingent take-home incentive and non-contingent take-home in methadone maintenance.

机构信息

Drug Prevention and Health Branch, United Nations Office on Drugs and Crime, Vienna, 1400, Austria.

出版信息

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Mar 30;35(2):483-9. doi: 10.1016/j.pnpbp.2010.12.002. Epub 2010 Dec 10.

DOI:10.1016/j.pnpbp.2010.12.002
PMID:21147192
Abstract

Methadone maintenance therapy (MMT) has been found effective in treating heroin addiction. Serious consideration should be given to the modality of methadone distribution, as it influences not only treatment outcome but the attitudes of policy makers and the community, too. On one hand, the choice of take-home methadone removes the need for daily attendance at a methadone clinic, which seems to improve patients' quality of life. On the other, this method, because of its lack of supervision and the absence of strict consumption monitoring, runs the risk of methadone misuse and diversion. In this study, we compared A) supervised daily consumption, B) contingent take-home incentives and C) non-contingent take-home in methadone maintenance in three groups of heroin-addicted patients attending three different MMT programmes. Retention rates at 12 months were significantly higher in contingent take-home patients (group B) than in those with supervised daily consumption (group A) and the non-contingent take-home (group C). Retention rates were higher in group A than in group C patients. Compared to patients in groups A and B, those in group C showed fewer negative urinalyses and higher rates of self-reported diversion and episodes of crime or violence. Results indicate a more positive outcomes following take-home methadone associated with behavioural incentives and other measures that aim to facilitate treatment compliance than those following daily supervised consumption. By contrast, non-contingent take-home methadone given to non-stabilized patients is associated with a high rate of diversion, along with more crime episodes and maladaptive behaviours.

摘要

美沙酮维持疗法(MMT)已被证实对治疗海洛因成瘾有效。美沙酮分发的方式应得到认真考虑,因为它不仅影响治疗效果,还影响政策制定者和社区的态度。一方面,选择带药回家可以减少每天到美沙酮诊所就诊的需要,这似乎提高了患者的生活质量。另一方面,这种方法由于缺乏监督和严格的消费监测,存在美沙酮滥用和转移的风险。在这项研究中,我们比较了三组海洛因成瘾患者在三种不同的美沙酮维持治疗方案中接受的 A)监督每日消费、B)附带带药回家奖励和 C)非附带带药回家。在 12 个月时,有附带带药回家奖励的患者(B 组)的保留率明显高于监督每日消费的患者(A 组)和非附带带药回家的患者(C 组)。A 组的保留率高于 C 组。与 A 组和 B 组的患者相比,C 组的患者尿检呈阴性的次数更少,自我报告的转移和犯罪或暴力事件的发生率更高。结果表明,与每日监督消费相比,带药回家与行为奖励和其他旨在促进治疗依从性的措施相关联,可产生更积极的结果。相比之下,非附带带药回家给予非稳定患者,与较高的转移率以及更多的犯罪事件和适应不良行为相关联。

相似文献

1
Supervised daily consumption, contingent take-home incentive and non-contingent take-home in methadone maintenance.美沙酮维持治疗中的监督性日摄食量、依情况发放可携出院奖励品和非依情况发放可携出院奖励品。
Prog Neuropsychopharmacol Biol Psychiatry. 2011 Mar 30;35(2):483-9. doi: 10.1016/j.pnpbp.2010.12.002. Epub 2010 Dec 10.
2
A randomized controlled trial of interim methadone maintenance.美沙酮维持治疗中期的一项随机对照试验。
Arch Gen Psychiatry. 2006 Jan;63(1):102-9. doi: 10.1001/archpsyc.63.1.102.
3
Earning "take-home" privileges and long-term outcome in a methadone maintenance treatment program.美沙酮维持治疗方案中获得“带出院”权限和长期结局
J Addict Med. 2011 Jun;5(2):92-8. doi: 10.1097/ADM.0b013e3181e6ad48.
4
Drug use, health and social outcomes of hard-to-treat heroin addicts receiving supervised injectable opiate treatment: secondary outcomes from the Randomized Injectable Opioid Treatment Trial (RIOTT).难以治疗的海洛因成瘾者接受监督注射阿片类药物治疗的药物使用、健康和社会结局:随机注射阿片类药物治疗试验(RIOTT)的次要结局。
Addiction. 2015 Mar;110(3):479-90. doi: 10.1111/add.12748. Epub 2014 Nov 7.
5
Physical and mental health in severe opioid-dependent patients within a randomized controlled maintenance treatment trial.严重阿片类药物依赖患者随机对照维持治疗试验中的身心健康。
Addiction. 2011 Sep;106(9):1647-55. doi: 10.1111/j.1360-0443.2011.03463.x. Epub 2011 Jul 22.
6
The impact of benzodiazepine use on methadone maintenance treatment outcomes.苯二氮䓬类药物的使用对美沙酮维持治疗效果的影响。
J Addict Dis. 2008;27(3):37-48. doi: 10.1080/10550880802122620.
7
Benzodiazepine use among patients in heroin-assisted vs. methadone maintenance treatment: findings of the German randomized controlled trial.苯二氮䓬类药物在海洛因辅助治疗与美沙酮维持治疗患者中的使用:德国随机对照试验的结果。
Drug Alcohol Depend. 2010 Dec 1;112(3):226-33. doi: 10.1016/j.drugalcdep.2010.06.013. Epub 2010 Aug 12.
8
Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study.低成本激励措施对美沙酮维持治疗中兴奋剂戒断的影响:一项国家药物滥用治疗临床试验网络研究。
Arch Gen Psychiatry. 2006 Feb;63(2):201-8. doi: 10.1001/archpsyc.63.2.201.
9
Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users.与海洛因使用者相比,处方类阿片类药物主要使用者在美沙酮维持药物治疗中的留存情况。
Addiction. 2009 May;104(5):775-83. doi: 10.1111/j.1360-0443.2009.02538.x. Epub 2009 Mar 13.
10
Controlled trial of prescribed heroin in the treatment of opioid addiction.处方海洛因治疗阿片类药物成瘾的对照试验。
J Subst Abuse Treat. 2006 Sep;31(2):203-11. doi: 10.1016/j.jsat.2006.04.007. Epub 2006 Jul 18.

引用本文的文献

1
Does a take-home dose program result in better patient adherence to methadone? Evidence from Vietnam.带回家剂量计划是否能提高患者对美沙酮的依从性?来自越南的证据。
Harm Reduct J. 2025 Jul 28;22(1):131. doi: 10.1186/s12954-025-01279-9.
2
Exploration of the multi-level barriers to scaling up methadone for HIV prevention among people who inject drugs in Kazakhstan.哈萨克斯坦扩大美沙酮用于预防注射吸毒者感染艾滋病毒的多层次障碍探索。
J Subst Use Addict Treat. 2025 May;172:209640. doi: 10.1016/j.josat.2025.209640. Epub 2025 Feb 20.
3
Examining inequities in access to opioid agonist treatment (OAT) take-home doses (THD): A Canadian OAT guideline synthesis and systematic review.
考察阿片类激动剂治疗 (OAT) 口服剂量 (THD) 可及性方面的不平等:加拿大 OAT 指南综合与系统评价。
Int J Drug Policy. 2024 May;127:104343. doi: 10.1016/j.drugpo.2024.104343. Epub 2024 Mar 29.
4
Retention and critical outcomes among new methadone maintenance patients following extended take-home reforms: a retrospective observational cohort study.延长带回家药物政策改革后新美沙酮维持治疗患者的留存率及关键结局:一项回顾性观察队列研究
Lancet Reg Health Am. 2023 Dec 4;28:100636. doi: 10.1016/j.lana.2023.100636. eCollection 2023 Dec.
5
Feasibility, Acceptability, and Preliminary Efficacy of a Smartphone-Based Contingency Management Intervention for Buprenorphine Adherence.基于智能手机的丁丙诺啡依从性应急管理干预措施的可行性、可接受性及初步疗效
Behav Anal Pract. 2022 Jul 13;16(2):450-458. doi: 10.1007/s40617-022-00730-8. eCollection 2023 Jun.
6
Patients' perceptions of self-administered dosing to opioid agonist treatment and other changes during the COVID-19 pandemic: a qualitative study.患者对 COVID-19 大流行期间阿片类激动剂治疗自我给药和其他变化的看法:一项定性研究。
BMJ Open. 2023 Mar 21;13(3):e069857. doi: 10.1136/bmjopen-2022-069857.
7
Interest without uptake: A mixed-methods analysis of methadone utilization in Kyrgyz prisons.无摄取兴趣:吉尔吉斯斯坦监狱中美沙酮利用的混合方法分析。
PLoS One. 2022 Oct 25;17(10):e0276723. doi: 10.1371/journal.pone.0276723. eCollection 2022.
8
Extended-release pharmacotherapy for opioid use disorder (EXPO): protocol for an open-label randomised controlled trial of the effectiveness and cost-effectiveness of injectable buprenorphine versus sublingual tablet buprenorphine and oral liquid methadone.用于治疗阿片类药物使用障碍的延长释放型药物治疗(EXPO):一项关于注射用丁丙诺啡与舌下含服丁丙诺啡片和口服美沙酮液有效性和成本效益的开放性随机对照试验的方案。
Trials. 2022 Aug 19;23(1):697. doi: 10.1186/s13063-022-06595-0.
9
COVID 19 and the Opioid Epidemic: An Analysis of Clinical Outcomes During COVID 19.新冠病毒 19 与阿片类药物流行:新冠病毒 19 期间临床结果分析
Subst Abuse. 2022 Apr 22;16:11782218221085590. doi: 10.1177/11782218221085590. eCollection 2022.
10
Lessons from the First Wave of COVID-19 for Improved Medications for Opioid Use Disorder (MOUD) Treatment: Benefits of Easier Access, Extended Take Homes, and New Delivery Modalities.从 COVID-19 第一波疫情中吸取教训,改善阿片类药物使用障碍(MOUD)治疗药物:更容易获得、延长带回家时间和新的给药方式的好处。
Subst Use Misuse. 2022;57(7):1144-1153. doi: 10.1080/10826084.2022.2064509. Epub 2022 Apr 21.